Aviva’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-137,413
Closed -$6.57M 865
2024
Q4
$6.57M Buy
137,413
+38,765
+39% +$1.85M 0.02% 502
2024
Q3
$5.65M Buy
98,648
+62,833
+175% +$3.6M 0.01% 463
2024
Q2
$1.88M Hold
35,815
0.01% 590
2024
Q1
$1.46M Buy
35,815
+20,131
+128% +$819K ﹤0.01% 625
2023
Q4
$580K Buy
15,684
+2,754
+21% +$102K ﹤0.01% 856
2023
Q3
$494K Sell
12,930
-575
-4% -$22K ﹤0.01% 879
2023
Q2
$487K Buy
13,505
+2,863
+27% +$103K ﹤0.01% 878
2023
Q1
$406K Buy
10,642
+1,616
+18% +$61.7K ﹤0.01% 945
2022
Q4
$514K Sell
9,026
-3,663
-29% -$208K ﹤0.01% 953
2022
Q3
$502K Buy
12,689
+3,016
+31% +$119K ﹤0.01% 952
2022
Q2
$426K Buy
+9,673
New +$426K ﹤0.01% 1023
2021
Q1
Sell
-47,332
Closed -$2.02M 958
2020
Q4
$2.02M Sell
47,332
-38,368
-45% -$1.64M 0.01% 676
2020
Q3
$2.25M Sell
85,700
-2,753
-3% -$72.3K 0.01% 723
2020
Q2
$2.37M Sell
88,453
-114,004
-56% -$3.06M 0.01% 599
2020
Q1
$3.64M Buy
+202,457
New +$3.64M 0.03% 563